I know there are obvious risks with DN poor circulation, sensation, non-healing wounds and diabetes. Especially distal extremities. I’m wondering if anyone has heard of using an A1c cutoff score or any objective clinical rules out there to help determine if DN treatment is safe to use on patients with diabetes? Or just use clinical judgment?
Thanks,
Mark
This is a great question Mark. I have not used that marker as a clinical onjective, nor have I seen it in the literature. Let me know if you find something in a lit review and will be curious to see if your colleagues have used this at all.